Homeopatia no combate ao cancro cerebral (estudo referente a Ruta graveolens e Calcarea Phosphorica)

Along with the Professor of Cell Biology and Genetics, at the University of Texas MD Anderson Cancer Center, Houston, one paper has been published entitled “Ruta 6 selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: A novel treatment for human brain cancer” in the International Journal of Oncology in October 2003 where our method of treatment with Ruta and Calcarea Phosphorica was followed with excellent results. 

In our observation for the last 30 years, these medicines have the definite power to reduce and cure Intracranial SOL. It may be interesting to note that our claims with regard to the action of these medicines have been successfully vindicated in vitro. These slides show Metaphases from control and Ruta 6-treated MGR-one human brain cancer cells showing mitotic catastrophe: 

A, normal metaphase spread from a control culture; 

B, endo-re-duplicated partial metaphase spread showing dicentrics, chromatid breaks, and tri-radial configurations; and 

C, an endoreduplicated metaphase with extensive chromosome fragmentations from Ruta-treated cultures. These slides show FISH (Fluorescent in-situ Hybridization) preparations of interphase cells from a human B-lymphoid cell line and MGR-one brain cancer either untreated or treated with Ruta 6 + Ca3(PO4)2 are stained with DAPI for DNA (blue), and telomeric DNA labeled with rhodamine (red). 

B-lymphoid control cells (A) 

and Ruta 6-treated cells (B) both show no reduction in telomeric signals. 

Untreated control (C) 

and Ruta-treated (D) … human brain cancer cells show significant difference in telomeric signals. Large nuclei from Ruta-treated cells show reduced telomeric signals. All microphotographs were taken at the same magnification. Both in vivo and in vitro results showed induction of survival-signaling pathways in normal lymphocytes and induction of death-signaling pathways in brain cancer cells. Cancer cell death was initiated by telomere erosion and completed through mitotic catastrophe events. We proposed that Ruta in combination with Ca3(PO4)2 could be used for effective treatment of brain cancers, particularly glioma.

Of interest in this context is the fact that the brain tumor community in the US has shown an immense response to this protocol of treatment. We all know that patients suffering from serious diseases often acquire a good deal of knowledge about their diseases. Lately, we have been receiving 60 to 70 mails a day from patients all over the world who have found the paper on Ruta and in an uncontrolled manner have started taking the medicines themselves. When after 3 to 4 months of treatment, they find that their tumor has regressed or become static, they contact us to fine tune the treatment for them. 

Some have even gone so far as to set up user groups on the internet which are showing remarkable results. One such group is run by Mr. Alex Fidelibus and can be accessed on the projected URL: “http://health.groups.yahoo.com/group/Ruta6/” 

Infusão de Matricaria Chamomilla inibe a proliferação de células Cancerígenas (Estudo Inglês)

Camomile tea 'fights cancer': Chemical contained in drink takes away 'superpowers' in disease's cells

• Tea contains a chemical, apigenin, which can halt the spread of cancer cells
• Camomile tea, parsley and celery are the most abundant sources of apigenin
• It is also found in many fruit and vegetables common in a Mediterranean diet

By DAILY MAIL REPORTER

PUBLISHED: 22:18 GMT, 21 May 2013 | UPDATED: 06:42 GMT, 22 May 2013

• Comments (25)
• Share

A cup of camomile tea could help ward off cancer, researchers say. 

The tea contains a chemical, apigenin, which takes away some of the ‘superpowers’ of cancer cells.

Scientists at Ohio State University found apigenin can block the ability of breast cancer cells to live far longer than normal cells, halting their spread and making them more sensitive to drug therapy. 

Camomile tea, parsley and celery are the most abundant sources of apigenin but it is also found in many fruit and vegetables common in a Mediterranean diet. 

Researchers have found that camomile tea contains a chemical, apigenin, which takes away some of the 'superpowers' of cancer cells

The chemical, which has also been shown to act as an anti-inflammatory, works in a way that suggests other nutrients could have similar effects in warding off cancer.

It helps proteins correct the abnormalities in RNA – molecules carrying genetic information – that are responsible for about 80 per cent of cancers.

Molecular geneticist Professor Andrea Doseff, of Ohio State University, said: 'We know we need to eat healthfully, but in most cases we do not know the actual mechanistic reasons for why we need to do that.

'We see here the beneficial effect on health is attributed to this dietary nutrient affecting many proteins.

More...

• Tuck in! Eating sweets regularly DOESN'T make you more likely to be fat or develop heart disease
• Anyone for Thai Green Curry crickets? Or BBQ worm crisps?: Selfridges reports 11% surge in EDIBLE INSECT sales

'In its relationship with a set of specific proteins, apigenin re-establishes the normal profile in cancer cells. We think this can have great value clinically as a potential cancer-prevention strategy.'

Cancer cells thrive by inhibiting a process that would cause them to die on a regular cycle subject to strict programming.

The researchers found apigenin could stop breast cancer cells from inhibiting their own death.

Apigenin - found in the tea - can block the ability of breast cancer cells to live far longer than normal cells, halting their spread

Much of what is known about the health benefits of nutrients is based on epidemiological studies that show strong positive relationships between eating specific foods and better health outcomes, especially reduced heart disease.

But how the actual molecules within these healthy foods work in the body is still a mystery in many cases, and especially with those linked to lower risk for cancer.

The researchers also showed apigenin binds with an estimated 160 proteins in the human body, suggesting other nutrients linked to health benefits called ‘nutraceuticals’ might have similar far reaching effects. In contrast, most pharmaceutical drugs target a single molecule.

The researchers, whose findings are published online in the Proceedings of the National Academy of Sciences, likened their technique to ‘fishing’ for the human proteins in cells that interact with small molecules available in the diet.

Prof Doseff said: 'You can imagine all the potentially affected proteins as tiny fishes in a big bowl. 

'We introduce this molecule to the bowl and effectively lure only the truly affected proteins based on structural characteristics that form an attraction.

'We know this is a real partnership because we can see that the proteins and apigenin bind to each other.'

Experiments established apigenin had relationships with proteins that have three specific functions.

Among the most important was one known as hnRNPA2 which influences tiny bits of DNA called mRNA containing the instructions needed to produce a specific protein. 

Abnormalities in these are responsible for about 80 percent of all cancers.

The researchers observed apigenin’s connection to the hnRNPA2 protein restored the function of mRNA to breast cancer cells, suggesting when they are normal cells die in a programmed way, or become more sensitive to chemotherapeutic drugs.

Added Prof Doseff: 'So by applying this nutrient, we can activate that killing machinery.'

The beneficial effects of nutraceuticals are not limited to cancer, as the investigators previously showed that apigenin has anti-inflammatory activities.

The scientists noted that with its multiple cellular targets, apigenin potentially offers a variety of additional benefits that may even occur over time.

The researchers are now testing whether food modified to contain proper doses of the nutrient can prevent cancer in mice.